ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS)

$20.06 -0.32 (-1.5702%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) News Sources

Asahi Kasei’s Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time

25-06-2026

yahoo.com

Asahi Kasei Microdevices Begins Mass Production of Camera‑less Modules for Detection of Falls, Vital Signs, Posture, and Position

15-07-2026

yahoo.com

Asahi Kasei Enters First License Agreement for Production and Sale of Acetolyte™ Novel Electrolyte in China

06-08-2026

yahoo.com

Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company’s 40-Year North American Battery Separator Strategy

26-08-2026

yahoo.com

Asahi Kasei Microdevices’ CZ39 and CZ3K Current Sensors Featured in Microchip Technology’s Machine Learning-Based Arc Fault Detection Reference Design

08-09-2026

yahoo.com

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing

15-09-2026

yahoo.com

Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei Therapeutics

29-09-2026

yahoo.com

Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients

08-10-2026

yahoo.com

Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall Elements

09-10-2026

yahoo.com

Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults

09-10-2026

yahoo.com

ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) Sentiment Trend

0 25 50 75 100 75 65 75 90 57 90 71 59 59 68 25-06-2026 15-07-2026 06-08-2026 26-08-2026 08-09-2026 15-09-2026 29-09-2026 08-10-2026 09-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) FAQs

toggle

What is the current price of ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS)?

The current price of ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) is $20.06.


toggle

ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) absolute price change since previous trading day?

The absolute price change of ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) since the previous trading day is $-0.32.


toggle

ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) percentage price change since previous trading day?

The percentage price change of ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) since the previous trading day is -1.5702%.


toggle

What is the most recent average sentiment score for ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS)?

The most recent average sentiment score for ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) is 71 out of 100.


toggle

What is the most recent average sentiment for ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS)?

The most recent sentiment for ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS) is .


SEC-8K** Filing Available For ASAHI KASEI CORP-UNSPON ADR (AHKSY:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.